Efficacy of exclusive enteral feeding as primary therapy for paediatric Crohn's disease;Eficacia del tratamiento nutricional primario en la enfermedad de Crohn pediátrica

Anales de Pediatria

Volumn 69, Issue 6, 2008, Pages 506-514

  Navas Lopez V M ^a   Blasco Alonso, J ^a   Sierra Salinas, C ^a   Barco Galvez A ^a   Vicioso Recio, M I ^b  

^a Nutrición Infantil Servicio de Pediatría España   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Calprotectin; Crohn's disease; Enteral nutrition; Inflammatory bowel disease; Nutritional therapy

Indexed keywords

CALGRANULIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; ENTERIC FEEDING; FECES ANALYSIS; FEMALE; HUMAN; MALE; REMISSION; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 59749089143     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/S1695-4033(08)75232-9     Document Type: Article

References (41)

1. Pajares J.M., and Gisbert J.P. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Esp Enferm Dig 93 (2001) 9-20
2. a ed. (2007), Adalia, Madrid
3. Morin C.L., Roulet M., Roy C.C., Weber A., and Lapointe N. Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr 6 (1982) 194-199
4. Griffiths A.M., Ohlsson A., Sherman P.M., and Sutherland L.R. Metaanalysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 108 (1995) 1056-1067
5. Heuschkel R.B., Menache C.C., Megerian J.T., and Baird A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 31 (2000) 8-15
6. Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., Bridger S., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 47 (2000) 506-513
7. Carroccio A., Iacono G., Cottone M., Di Prima L., Cartabellotta F., Cavataio F., et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: A prospective study in adults and children. Clin Chem 49 (2003) 861-867
8. Fagerberg U.L., Lööf L., Lindholm J., Hansson L.O., and Finkel Y. Fecal calprotectin: A quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 45 (2007) 414-420
9. Fagerberg U.L., Lööf L., Myrdal U., Hansson L., and Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 40 (2005) 450-455
10. Berni Canani R., Rapacciuolo L., Romano M.T., Tanturri de Horatio L., Terrin G., Manguso F., et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 36 (2004) 467-470
11. Konikoff M.R., and Denson L.A. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 524-534
12. Røseth A.G., Aadland E., and Grzyb K. Normalization of faecal calprotectin: A predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 39 (2004) 1017-1020
13. Sierra C., Blasco J., Ranchal P., Barco A., Del Río L., and Vicioso I. Fecal calprotectin as a noninvasive measure of disease activity in childhood inflammatory bowel disease (IBD). J Pediatr Gastroenterol Nutr 39 (2004) S316-S317
14. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
15. Hyams J.S., Ferry G.D., Mandel F.S., Gryboski J.D., Kibort P.M., Kirschner B.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
16. Griffiths A.M. Enteral nutrition in the management of Crohn's disease. J Parenter Enteral Nutr 29 (2005) S108-S112
17. Verma S., Brown S., Kirkwood B., and Giaffer M.H. Polymeric versus elemental diet as primary treatment in active Crohn's disease: A randomized, double-blind trial. Am J Gastroenterol 95 (2000) 735-739
18. Ludvigsson J.F., Krantz M., Bodin L., Stenhammar L., and Lindquist B. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: A multicentre randomized controlled trial. Acta Paediatr 93 (2004) 327-335
19. Zachos M., Tondeur M., and Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 24 (2007) CD000542
20. Akobeng A.K., Miller V., Stanton J., Elbadri A.M., and Thomas A.G. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 30 (2000) 78-84
21. Khoshoo V., Reifen R., Neuman M.G., Griffiths A., and Pencharz P.B. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. J Parenter Enteral Nutr 20 (1996) 401-405
22. Hanauer S.B., and Strömberg U. Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2 (2004) 379-388
23. Sutherland L., Singleton J., and Session J. Double-blind, placebocontrolled trial of metronidazole in Crohn's disease. Gut 32 (1991) 1071-1075
24. Sanderson I.R., Udeen S., Davies P.S., Savage M.O., and Walker-Smith J.A. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 62 (1987) 123-127
25. Ruuska T., Savilahti E., Maki M., Ormala T., and Visakorpi J.K. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 19 (1994) 175-180
26. Thomas A.G., Taylor F., and Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 17 (1993) 75-81
27. Papadopoulou A., Rawashdeh M.O., Brown G.A., McNeish A.S., and Booth I.W. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr 84 (1995) 79-83
28. Fell J.M., Paintin M., Arnaud-Battandier F., Beattie R.M., Hollis A., Kitching P., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14 (2000) 281-289
29. Terrin G., Berni Canani R., Ambrosini A., Viola F., Bueno de Mesquita M., Di Nardo G., et al. A semielemental diet (Pregomin) as primary therapy for inducing remission in children with active Crohn's disease. Ital J Pediatr 28 (2002) 401-405
30. Afzal N.A., Van Der Zaag-Loonen H.J., Arnaud-Battandier F., Davies S., Murch S., Derkx B., et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 20 (2004) 167-172
31. Knight C., El-Matary W., Spray C., and Sandhu B.K. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 24 (2005) 775-779
32. Day A.S., Whitten K.E., Lemberg D.A., Clarkson C., Vitug-Sales M., Jackson R., et al. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: A feasible and effective approach. J Gastroenterol Hepatol 21 (2006) 1609-1614
33. Borrelli O., Cordischi L., Cirulli M., Paganelli M., Labalestra V., Uccini S., et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: A randomized controlled open-label trial. Clin Gastroenterol Hepatol 4 (2006) 744-753
34. Johnson T., Macdonald S., Hill S.M., Thomas A., and Murphy M.S. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: A randomised controlled trial. Gut 55 (2006) 356-361
35. Berni Canani R., Terrin G., Borrelli O., Romano M.T., Manguso F., Coruzzo A., et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids i paediatric Crohn's disease. Dig Liver Dis 38 (2006) 381-387
36. Rodrigues A.F., Johnson T., Davies P., and Murphy M.S. Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?. Arch Dis Child 92 (2007) 767-770
37. Beattie R.M., Schiffrin E.J., Donnet-Hughes A., Huggett A.C., Domizio P., MacDonald T.T., et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 8 (1994) 609-615
38. Fernández-Banares F., Cabré E., Esteve-Comas M., and Gassull M.A. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 19 (1995) 356-364
39. Messori A., Trallori G., D'Albasio G., Milla M., Vannozzi G., and Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: A meta-analysis. Scand J Gastroenterol 31 (1996) 267-272
40. Heuschkel R.B., Menache C.C., Megerian J.T., and Baird A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 31 (2000) 8-15
41. Dziechciarz P., Horvath A., Shamir R., and Szajewska H. Meta-analysis: Enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 26 (2007) 795-806